The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk's Wegovy and Eli Lilly's Zepbound.
GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today released a new Weight Loss Medications ...
The NHS spending watchdog said about 220,000 people could benefit from the drug in an initial three-year period ...
The new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that ...
As 'ballet body' beauty standards return, skin care that tackles elasticity and volume restoration will be in demand, with ...
A Citigroup report predicts global uptake of weight loss drugs like Ozempic will reach hundreds of millions by 2035. Here's ...
West Virginia’s Public Employee Insurance Agency is in a bind. Medical inflation continues to drive up health care costs and the PEIA finance board is looking for ways to save ...
The state pharmacy board placed two Nevada pharmacists on probation after they dispensed faulty weight loss drugs to local ...
A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the ...
CEO of UnitedHealthcare shot and killed in New York; More snow predicted for hard-hit Great Lakes region; New study compares ...
A study of two popular weight loss drugs, Zepbound and Wegovy, found that Zepbound was more effective helping people lose ...
Speaking at The New York Times’s DealBook Summit, Eli Lilly’s chief executive and an obesity medicine specialist discussed ...